<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
    <channel>
        <managingEditor>CEVA</managingEditor>
        <description>CEVA RSS Feed</description>
        <pubDate>Wed, 15 Apr 2026 22:01:15 +0200</pubDate>
        <language>eng-GB</language>
        <docs>http://www.rssboard.org/rss-specification</docs>
        <title>Ceva Biovac RSS</title>
        <link>https://www.ceva-biovac-campus.com/en</link>
        <item>
            <title>Ceva Swine Offer</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-Swine-Offer</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-Swine-Offer</guid>
            <description><![CDATA[Complementarities between swine autogenous vaccines produced by Ceva Biovac and Ceva swine offer.]]></description>
            <pubDate>Thu, 7 Sep 2017 10:13:06 +0200</pubDate>
        </item>
        <item>
            <title>Ceva opens new production facility in Lenexa, Kansas</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-opens-new-production-facility-in-Lenexa-Kansas</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-opens-new-production-facility-in-Lenexa-Kansas</guid>
            <description><![CDATA[May 3, 2011, Lenexa, Kan. –– Ceva Animal Health is pleased to announce the May 3, 2011 opening of a new poultry vaccine production facility at its Biomune Campus in Lenexa, Kansas.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:53 +0200</pubDate>
        </item>
        <item>
            <title>Ceva conducts latest of its Expert Symposia</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-conducts-latest-of-its-Expert-Symposia</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-conducts-latest-of-its-Expert-Symposia</guid>
            <description><![CDATA[Veterinary specialists gather in Madrid to discuss latest trends in sow reproduction]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:52 +0200</pubDate>
        </item>
        <item>
            <title>Ceva finishes first decade of success with strong growth</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-finishes-first-decade-of-success-with-strong-growth</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-finishes-first-decade-of-success-with-strong-growth</guid>
            <description><![CDATA[2010 results demonstrate global ability to generate sales and earnings]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:51 +0200</pubDate>
        </item>
        <item>
            <title>Ceva continues to deliver double-digit growth</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-continues-to-deliver-double-digit-growth</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-continues-to-deliver-double-digit-growth</guid>
            <description><![CDATA[Sales up 20% versus S1 2016, driven by organic growth and acquisitions]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:50 +0200</pubDate>
        </item>
        <item>
            <title>Ceva launches latest of its Vector Vaccines at VIV Asia 2011</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-launches-latest-of-its-Vector-Vaccines-at-VIV-Asia-2011</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-launches-latest-of-its-Vector-Vaccines-at-VIV-Asia-2011</guid>
            <description><![CDATA[VECTORMUNE HVT- NDV® generates strong interest at symposium organised to present new strategies to combat Newcastle Disease.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:50 +0200</pubDate>
        </item>
        <item>
            <title>Ceva announces important advances in  the control of respiratory disease in poultry</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-announces-important-advances-in-the-control-of-respiratory-disease-in-poultry</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-announces-important-advances-in-the-control-of-respiratory-disease-in-poultry</guid>
            <description><![CDATA[Ceva Vaccination Summit details new claims for IB Vaccines.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:48 +0200</pubDate>
        </item>
        <item>
            <title>Ceva Phylaxia inaugurates state of the art vaccine plant to support “Innovation with Impact” growth plan</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-Phylaxia-inaugurates-state-of-the-art-vaccine-plant-to-support-Innovation-with-Impact-growth-plan</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-Phylaxia-inaugurates-state-of-the-art-vaccine-plant-to-support-Innovation-with-Impact-growth-plan</guid>
            <description><![CDATA[7,8 billion forint (€ 25m) investment will significantly increase production at its Budapest Campus]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:48 +0200</pubDate>
        </item>
        <item>
            <title>World Veterinary Association and Ceva Santé Animale announce the creation of the Global Animal Welfare Awards 2017 </title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/World-Veterinary-Association-and-Ceva-Sante-Animale-announce-the-creation-of-the-Global-Animal-Welfare-Awards-2017</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/World-Veterinary-Association-and-Ceva-Sante-Animale-announce-the-creation-of-the-Global-Animal-Welfare-Awards-2017</guid>
            <description><![CDATA[As global understanding and concern for animal welfare continues to change, so must the veterinary community evolve to embrace these changes and reflect societal expectations.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:47 +0200</pubDate>
        </item>
        <item>
            <title>Ceva shines light on the future with focus on innovation during VIV Asia 2017</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-shines-light-on-the-future-with-focus-on-innovation-during-VIV-Asia-2017</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-shines-light-on-the-future-with-focus-on-innovation-during-VIV-Asia-2017</guid>
            <description><![CDATA[Ceva’s teams brought innovation to the fore during VIV Asia 2017]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:47 +0200</pubDate>
        </item>
        <item>
            <title>Ceva honours rare livestock breeds during the French National Prize for Animal Agro biodiversity Awards ceremony</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-honours-rare-livestock-breeds-during-the-French-National-Prize-for-Animal-Agro-biodiversity-Awards-ceremony</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-honours-rare-livestock-breeds-during-the-French-National-Prize-for-Animal-Agro-biodiversity-Awards-ceremony</guid>
            <description><![CDATA[The Fondation du Patrimoine and Ceva Santé Animale awarded the “Fondation du Patrimoine National Animal Agro-Biodiversity Prize” to 3 associations committed to preserving regional livestock breed, during the Paris International Agricultural Show.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:46 +0200</pubDate>
        </item>
        <item>
            <title>  Ceva reinforces its position in China and swine through new joint-venture with EBVAC  </title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-reinforces-its-position-in-China-and-swine-through-new-joint-venture-with-EBVAC</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-reinforces-its-position-in-China-and-swine-through-new-joint-venture-with-EBVAC</guid>
            <description><![CDATA[In the presence of the Chinese Prime Minister, Li Keqiang and French Prime Minister, Bernard Cazeneuve, Ceva Santé Animale (Ceva) and EBVAC today signed a joint-venture agreement to create a new business, Ceva EBVAC, focused on the swine sector.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:45 +0200</pubDate>
        </item>
        <item>
            <title>Launch of the WVPA-Ceva joint Digital Library</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Launch-of-the-WVPA-Ceva-joint-Digital-Library</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Launch-of-the-WVPA-Ceva-joint-Digital-Library</guid>
            <description><![CDATA[Launch of a digital library resource on poultry veterinary medicine]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:44 +0200</pubDate>
        </item>
        <item>
            <title>Ceva stresses the need for continued innovation  to ensure effective disease control at IPPE 2017</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-stresses-the-need-for-continued-innovation-to-ensure-effective-disease-control-at-IPPE-2017</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-stresses-the-need-for-continued-innovation-to-ensure-effective-disease-control-at-IPPE-2017</guid>
            <description><![CDATA[Vectormune® ND, vaccine for Newcastle Disease (ND) Cevac IBird®, for Infectious Bronchitis (IB) prevention will continue to lead offerings for effective and easily administered disease control.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:44 +0200</pubDate>
        </item>
        <item>
            <title>Ceva Santé Animale confirms its circle of virtuous growth in 2016</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-Sante-Animale-confirms-its-circle-of-virtuous-growth-in-2016</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-Sante-Animale-confirms-its-circle-of-virtuous-growth-in-2016</guid>
            <description><![CDATA[2016 was a year of sustained organic growth and major acquisitions. Consolidated sales reached €912m as the Ceva Group continued to achieve double-digit growth, cementing its position as the 6th. largest animal health company.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:44 +0200</pubDate>
        </item>
        <item>
            <title>Ceva completes deal to acquire portfolio of Merial swine &amp; cattle vaccines and nonsteroidal anti-inflammatories from Boehringer Ingelheim</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-completes-deal-to-acquire-portfolio-of-Merial-swine-cattle-vaccines-and-nonsteroidal-anti-inflammatories-from-Boehringer-Ingelheim</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-completes-deal-to-acquire-portfolio-of-Merial-swine-cattle-vaccines-and-nonsteroidal-anti-inflammatories-from-Boehringer-Ingelheim</guid>
            <description><![CDATA[19 January 2017: Ceva Santé Animale today completed the acquisition of a diversified portfolio of products, including swine and cattle vaccines and multi-species nonsteroidal anti-inflammatories from Boehringer Ingelheim following its acquisition of Merial Animal Health.   All the products will be immediately available through local Ceva companies or its distributors, with no interruption of supply.   Ceva has been consistently one of the fastest growing top 10 veterinary businesses in the last decade, investing heavily in the development of vaccines, as part of its global preventative health strategy.   Commenting on the deal, Ceva Chairman &amp; CEO Dr. Marc Prikazsky said:   “We are delighted to acquire this range of products and strong pipeline of R&amp;D assets. The knowhow behind these products dates from Pasteur, Rhone-Merieux, Merial and now as Ceva we are conscious that we have a responsibility to maintain this strong veterinary scientific tradition. Our customers can be assured that we will continue to invest to develop the products of both today and tomorrow.”   &gt;&gt; Download the PDF version:  ]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:43 +0200</pubDate>
        </item>
        <item>
            <title>Ceva Santé Animale given European Commission go ahead to acquire Merial assets from Boehringer Ingelheim</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-Sante-Animale-given-European-Commission-go-ahead-to-acquire-Merial-assets-from-Boehringer-Ingelheim</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-Sante-Animale-given-European-Commission-go-ahead-to-acquire-Merial-assets-from-Boehringer-Ingelheim</guid>
            <description><![CDATA[The European Commission recently gave its approval for the transfer to Ceva Santé Animale of nine products developed and currently marketed by Merial.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:42 +0200</pubDate>
        </item>
        <item>
            <title>Ceva acquires Hertape and Inova to enter Brazil’s top 5 animal health companies</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-acquires-Hertape-and-Inova-to-enter-Brazil-s-top-5-animal-health-companies</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-acquires-Hertape-and-Inova-to-enter-Brazil-s-top-5-animal-health-companies</guid>
            <description><![CDATA[Move will increase the group global vaccine footprint with significant entry into the ruminant, Foot and Mouth disease market and a first entry into companion animal vaccines.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:42 +0200</pubDate>
        </item>
        <item>
            <title>C.H.I.C.K Program receives the 1st independently audited quality recognition</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/C.H.I.C.K-Program-receives-the-1st-independently-audited-quality-recognition</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/C.H.I.C.K-Program-receives-the-1st-independently-audited-quality-recognition</guid>
            <description><![CDATA[For the first time, an AH company services program receives internationally recognized quality approval from Bureau Veritas.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:41 +0200</pubDate>
        </item>
        <item>
            <title>Ceva sponsors IAHAIO Conference held in Paris</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-sponsors-IAHAIO-Conference-held-in-Paris</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-sponsors-IAHAIO-Conference-held-in-Paris</guid>
            <description><![CDATA[Ceva reiterates its commitment to promoting the benefits of human-animal interaction (HAI)]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:40 +0200</pubDate>
        </item>
        <item>
            <title>Ceva sponsors the International Symposium on Marek’s Disease and Avian Herpes viruses organised by INRA, France </title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-sponsors-the-International-Symposium-on-Marek-s-Disease-and-Avian-Herpes-viruses-organised-by-INRA-France</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-sponsors-the-International-Symposium-on-Marek-s-Disease-and-Avian-Herpes-viruses-organised-by-INRA-France</guid>
            <description><![CDATA[11th International Symposium on Marek’s Disease and Avian Herpes viruses organized in Tours, France]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:39 +0200</pubDate>
        </item>
        <item>
            <title>Ceva posts strong double-digit organic growth once again in first half of 2016 </title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-posts-strong-double-digit-organic-growth-once-again-in-first-half-of-2016</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-posts-strong-double-digit-organic-growth-once-again-in-first-half-of-2016</guid>
            <description><![CDATA[Ceva&#039;s results]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:39 +0200</pubDate>
        </item>
        <item>
            <title>Avian Flu - Ceva&#039;s reveals plans to develop new AI H7 vaccine during latest summit in Mexico</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Avian-Flu-Ceva-s-reveals-plans-to-develop-new-AI-H7-vaccine-during-latest-summit-in-Mexico</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Avian-Flu-Ceva-s-reveals-plans-to-develop-new-AI-H7-vaccine-during-latest-summit-in-Mexico</guid>
            <description><![CDATA[Ceva gathered experts from around the world to share the latest findings on the global threat posed by Avian Influenza (AI)]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:38 +0200</pubDate>
        </item>
        <item>
            <title>Ceva acquires Biovac, leading French manufacturer of Autogenous vaccines</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-acquires-Biovac-leading-French-manufacturer-of-Autogenous-vaccines</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-acquires-Biovac-leading-French-manufacturer-of-Autogenous-vaccines</guid>
            <description><![CDATA[Move will reinforce group’s AMR strategy to find alternative solutions to use of antibiotics]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:37 +0200</pubDate>
        </item>
        <item>
            <title>One Health put into practice: Veterinary and human cardiologists discuss cardiovascular disease in pets</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/One-Health-put-into-practice-Veterinary-and-human-cardiologists-discuss-cardiovascular-disease-in-pets</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/One-Health-put-into-practice-Veterinary-and-human-cardiologists-discuss-cardiovascular-disease-in-pets</guid>
            <description><![CDATA[Paris, February 2016 - ‘Making tomorrow happen today’ was the theme of the human-veterinary cross-talk symposium organised by Ceva on February 19.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:36 +0200</pubDate>
        </item>
        <item>
            <title>&quot;Healthier flocks for healthy food&quot; - Ceva Poultry Vaccinology Summit in Barcelona</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Healthier-flocks-for-healthy-food-Ceva-Poultry-Vaccinology-Summit-in-Barcelona</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Healthier-flocks-for-healthy-food-Ceva-Poultry-Vaccinology-Summit-in-Barcelona</guid>
            <description><![CDATA[This Summit provided the first scientific evidence that vaccination in the hatchery with new technology vaccines can create a step change from disease protection to disease prevention, by minimizing the spread and therefore circulation of field viruses.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:35 +0200</pubDate>
        </item>
        <item>
            <title>Ceva reports annual growth of 12% and reaffirms  ambition to enter the global top 5 by 2020 </title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-reports-annual-growth-of-12-and-reaffirms-ambition-to-enter-the-global-top-5-by-2020</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-reports-annual-growth-of-12-and-reaffirms-ambition-to-enter-the-global-top-5-by-2020</guid>
            <description><![CDATA[Raft of new product launches across significant markets powers strong sales in 2015]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:34 +0200</pubDate>
        </item>
        <item>
            <title> Ceva enters Indian market with acquisition of Polchem</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-enters-Indian-market-with-acquisition-of-Polchem</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-enters-Indian-market-with-acquisition-of-Polchem</guid>
            <description><![CDATA[Strong customer technical support will provide a natural platform for the coming together of the 2 businesses.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:34 +0200</pubDate>
        </item>
        <item>
            <title>Nomination of David Derain as Global Human Resources Director</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Nomination-of-David-Derain-as-Global-Human-Resources-Director</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Nomination-of-David-Derain-as-Global-Human-Resources-Director</guid>
            <description><![CDATA[David Derain joins the Ceva Santé Animale Group as Global Human Resources Director and member of the Executive Committee, with effect from 1st February 2016.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:32 +0200</pubDate>
        </item>
        <item>
            <title>Ecat and iD Projects in exclusive negotiation to create a global leader in hatchery equipment </title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ecat-and-iD-Projects-in-exclusive-negotiation-to-create-a-global-leader-in-hatchery-equipment</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ecat-and-iD-Projects-in-exclusive-negotiation-to-create-a-global-leader-in-hatchery-equipment</guid>
            <description><![CDATA[Libourne, 5 February 2016 – Ceva Santé Animale, through its subsidiary Ecat has entered exclusive negotiations with iD Projects to merge the two businesses.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:31 +0200</pubDate>
        </item>
        <item>
            <title>Ceva Australia commits to save the koalas</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-Australia-commits-to-save-the-koalas</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-Australia-commits-to-save-the-koalas</guid>
            <description><![CDATA[Animal health company donates drugs to cure life-threatening disease]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:30 +0200</pubDate>
        </item>
        <item>
            <title>Franck Pelissou appointed Managing Director of Ecat, the Ceva Santé Animale subsidiary based in Brittany, France</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Franck-Pelissou-appointed-Managing-Director-of-Ecat-the-Ceva-Sante-Animale-subsidiary-based-in-Brittany-France</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Franck-Pelissou-appointed-Managing-Director-of-Ecat-the-Ceva-Sante-Animale-subsidiary-based-in-Brittany-France</guid>
            <description><![CDATA[  Libourne, 10th December 2015: Franck Pelissou was recently appointed as Managing Director of Ecat, a subsidiary of Ceva Santé Animale, the global veterinary health company. Based in Landivisiau, Brittany, France, Ecat specialises in hatchery automation systems, manufacturing equipment for egg and chick handling, candling and in-ovo vaccination. Ceva aims to grow the company both internationally and in France by strengthening local after-sales service through both the Ecat and Ceva networks.   Franck has wide experience in the industrial technology sector. A graduate of Tarbes ENI engineering school, he began his career at Liebherr Aerospace. In 1995 he joined the automotive technology company, Valeo, where he worked until joining Ceva in 2008 as Industrial Performance Manager.   &gt;&gt; Ecat information sheet   Address: Zone Industrielle du Vern, 38 rue Alfred Nobel, 29400 Landivisiau, France Turnover in 2014: €8.6 million Headcount: 64 Management:  Franck Pelissou, Managing Director Alain Schrumpf, Sales Director Jean-Hubert Glémot, After-sales Director   &gt;&gt; Download the PDF version  ]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:29 +0200</pubDate>
        </item>
        <item>
            <title>Ceva to focus on science of Vaccinology during Budapest Poultry Summit </title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-to-focus-on-science-of-Vaccinology-during-Budapest-Poultry-Summit</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-to-focus-on-science-of-Vaccinology-during-Budapest-Poultry-Summit</guid>
            <description><![CDATA[Libourne 20th April 2015 - On April 28 - 30 in Budapest, Hungary, Ceva will hold its yearly summit designed to help poultry producers improve performance by increasing their awareness of the most innovative and integrated healthcare strategies]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:27 +0200</pubDate>
        </item>
        <item>
            <title>Ceva’s commitment to cats rewarded with 2 International Cat Care Awards</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-s-commitment-to-cats-rewarded-with-2-International-Cat-Care-Awards</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-s-commitment-to-cats-rewarded-with-2-International-Cat-Care-Awards</guid>
            <description><![CDATA[Libourne, 22 September 2015 - In recognition of their commitment to producing feline friendly products, Ceva Animal Health have received two industry awards.   At a prestigious event in London last week, Zodon and Vectra Felis from Ceva’s feline range, both received International Cat Care (ICC) Easy to Give Awards 2015.   Zodon is the first clindamycin to offer a flavoured oral solution for cats; as a commonly prescribed antibiotic it has only previously been available in tablet form. Vectra Felis is a new ectoparasiticide which kills on contact for a month and prevents flea reproduction for three months.     The proud double award winning Ceva team with members of ICC: From L to R Lindsay Johnson (Ceva), Allison Henry (Ceva), Claire Bessant, Nicola Barclay, Bradley Viner, Marie Laure Loubiere, Ginette Bryant (Ceva) &amp;amp;amp; Sarah Endersby (Ceva)   The ICC Easy to Give Awards recognise the investment in innovation by pharmaceutical companies who aim to make dosing cats easier.   Ginette Bryant, Communication Manager for Ceva Animal Health commented on the awards saying: “These awards recognise the positive impact of companies investing in innovation, aimed at making animal health products more feline friendly. Medicines that are easier to administer make life less stressful for vets, owners and feline patients alike. Not only that, in the case of antibiotics we know that owner compliance is a key factor in ensuring that dose protocols are respected, a key element in the battle against the onset of resistance&quot; .   Each award is the considered decision of the ICC feline expert panel, a group of veterinary surgeons who are, or have been, funded at vet schools to specialise in feline medicine by the ICC.   In total, since the awards’ conception in 2005, an impressive 6 Ceva Animal Health products have received ICC Easy to Give Awards, earning the company the right to display the ICC Easy to Give logo on packaging advertising materials.   &amp;amp;amp;amp;gt;&amp;amp;amp;amp;gt; Download the Press Release in PDF:  ]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:24 +0200</pubDate>
        </item>
        <item>
            <title>Experts from around the world gather to discuss the global threat of AI: “the US will be prepared to vaccinate if necessary”</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Experts-from-around-the-world-gather-to-discuss-the-global-threat-of-AI-the-US-will-be-prepared-to-vaccinate-if-necessary</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Experts-from-around-the-world-gather-to-discuss-the-global-threat-of-AI-the-US-will-be-prepared-to-vaccinate-if-necessary</guid>
            <description><![CDATA[Mid-September, experts from around the world gathered in Cape Town, South Africa to discuss the threat of Avian Influenza (AI) to global poultry stocks. A two hour symposium, hosted by global animal health company Ceva Santé Animale, bought together experts from the United States, China, the Netherlands and France. The meeting sought to understand the continuing threat posed by AI and the value of vaccination in changing times.   To date, 2015 has seen 309 individual outbreaks of Avian Influenza (AI) reported to the World Organisation for Animal Health (OIE), which is a staggering 147% increase on outbreaks reported in 2014. In the US alone during the last six months, 48 million domestic poultry birds (layers and turkeys) have been culled in the United States due to AI, with the disease spreading across 15 states. [1] It has been the worst epidemic of HPAI ever in the US and despite the outbreak seemingly under control, there are fears that AI could reappear this autumn following outbreaks across 31 countries already this year. [2]   Dr Mark Davidson, Associate Deputy Administrator of the National Import Export Services at the United States Department of Agriculture stated that: “We have taken tremendous effort to prepare for this fall, on the potential that there may be additional introductions (of AI) as the migratory birds come back from the north.” He continued, “We will be prepared to vaccinate if necessary.”   To date the USA is yet to vaccinate any of its poultry flocks, but Dr Yannick Gardin, Director of Science and Innovation at Ceva said today that: &quot;Many dogmas have grown up surrounding the control of Avian flu. Countries who decided to vaccinate were viewed as the bad countries, this is no longer appropriate.”   AI has proven to be a major threat for the global poultry industry, disrupting international trade and inducing high levels of mortality and economical losses in infected flocks. Emerging markets especially struggle to fight and recover from the disease, and decreasing public research funds only compound the issue. Nevertheless, there is still a debate raging amongst poultry industry experts and government officials, particularly in the USA, on the necessity of AI vaccination.   Professor Liu Xiufan, researcher and professor at Yangzhou University in Jiangsu, China stated that: “We learnt several lessons from the vaccination programme employed in China employed in response to the AI outbreak. Firstly, for the H5N1 HPA1, the best control strategy is to stamp out the outbreaks at the early stage. Vaccination can raise the level of flock protective immunity, increase the resistance to infection, and reduce virus replication and shredding. Secondly, vaccination must be incorporated with other methods such as biosecurity in farms, live bird markets and control of movements.”   Dr Andre Steentjes, Poultry Veterinarian and member of the Poultry Veterinary Study Group of the EU concluded that the takes home messages were: “that countries need a good AI monitoring system, especially with free range birds and an early warning system – decide when you should make warnings public.” He also commented on the inconsistencies in public opinion, because often “people want the birds to be outside and don’t realise they are at risk of catching AI.”   To find out more about AI and the benefits of vaccination with Vectormune ® AI, visit: www.avian-influenza-vaccines.com     [1] USDA information site, http://tinyurl.com/l75hk53 [2] OIE data, http://www.oie.int/en/animal-health-in-the-world/update-on-avian-influenza/2014/       &amp;amp;gt;&amp;amp;gt; Download the Press Release in PDF:  ]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:24 +0200</pubDate>
        </item>
        <item>
            <title>US stockpiles bird flu vaccine ahead of fears an outbreak could occur this autumn</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/US-stockpiles-bird-flu-vaccine-ahead-of-fears-an-outbreak-could-occur-this-autumn</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/US-stockpiles-bird-flu-vaccine-ahead-of-fears-an-outbreak-could-occur-this-autumn</guid>
            <description><![CDATA[Decision follows much consultation with experts following devastating outbreaks across the country already in 2015.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:24 +0200</pubDate>
        </item>
        <item>
            <title>Ceva to showcase latest hatchery innovations during World Veterinary Poultry Association congress</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-to-showcase-latest-hatchery-innovations-during-World-Veterinary-Poultry-Association-congress</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-to-showcase-latest-hatchery-innovations-during-World-Veterinary-Poultry-Association-congress</guid>
            <description><![CDATA[Libourne 31th August 2015 – The XIXth World Veterinary Poultry Association (WVPA) congress takes place on September (7th- 11th) in Cape Town, South Africa with Ceva as a diamond sponsor. The congress gathers more than a thousand poultry specialists from around the world and presents an excellent opportunity to build and develop profitable exchanges and relationships.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:23 +0200</pubDate>
        </item>
        <item>
            <title>Ceva posts strong double-digit growth again in H1 2015</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-posts-strong-double-digit-growth-again-in-H1-2015</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-posts-strong-double-digit-growth-again-in-H1-2015</guid>
            <description><![CDATA[Libourne 22 nd July 2015 - Consolidated sales of the Ceva Group reached €424m at the end of June 2015, representing growth of 16% and +12% at constant perimeter and exchange rates.   Sales grew in all zones, except Europe which was stable versus last year, with strong performance in North America/Pacific region (+43%), Asia (+38%) and Latin America (+26%).   All species are growing, especially Poultry (+27% globally and +35% on vaccines) and Companion Animals (+13%).   The group delivered an operational result slightly ahead of the budgeted objective and continued to make significant investment in R&amp;D (c.9% of sales).   Marc Prikazsky, Ceva’s Chairman and CEO commented, “The growth of the group remains consistent and ahead of our 2020 business plan. It’s very pleasing to see that our previous investment to develop innovative new technology vaccines is being rewarded with increased business from our poultry customers. We have a significant new pipeline of products to launch, which will further boost our business in companion animals, swine and dairy.”   &gt;&gt; Download the Press Release in PDF:  ]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:22 +0200</pubDate>
        </item>
        <item>
            <title>French Prime Minister Manuel Valls visits Ceva Santé Animale</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/French-Prime-Minister-Manuel-Valls-visits-Ceva-Sante-Animale</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/French-Prime-Minister-Manuel-Valls-visits-Ceva-Sante-Animale</guid>
            <description><![CDATA[Libourne, 24 July 2015 – French Prime Minister Manuel Valls visited Ceva’s headquarters in Libourne, to meet Dr. Marc Prikazsky and other business leaders from the local Aquitaine region.       Prime Minister Manuel Valls visits Ceva with Marc Prikazsky      The Prime Minister was accompanied by a large delegation including Alain Rousset, President of the Aquitaine region. The company has recently invested over €20 million in its Libourne site to ensure its infrastructure is of the best available global standard.   For Marc Prikazsky, Ceva Santé Animale CEO, &quot; The visit of the Prime Minister is I believe recognition for the dynamism of the French veterinary sector. Collectively we represent 20% of the world market. Ceva stands out in this sector because of its unique shareholder structure, which has helped us to deliver double digit growth for more than a decade. Hopefully, we have show that it is possible to grow and do business internationally while continuing to invest heavily in France. I believe in Europe’s industrial future because we have highly trained people and all the skills necessary to succeed, provided we continue to invest in state of the art facilities to remain globally competitive. &quot;   An encounter with midcaps   The Prime Minister’s visit to Ceva also included a meeting with business leaders who are members of the Aquitaine Intermediate-Sized Business Club chaired by Dr.Prikazsky. The Club is the only one of its kind in France and currently counts 42 business leaders from the industrial and corporate services sector based in the Aquitaine region. Together, they have combined sales of €5.5 billion and employ over 30,000 people.   &gt;&gt; Download the Press Release in PDF:  ]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:22 +0200</pubDate>
        </item>
        <item>
            <title>Ceva’s new generation Vectormune® AI vaccine proves to be a useful tool to control HPAI</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-s-new-generation-Vectormune-R-AI-vaccine-proves-to-be-a-useful-tool-to-control-HPAI</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-s-new-generation-Vectormune-R-AI-vaccine-proves-to-be-a-useful-tool-to-control-HPAI</guid>
            <description><![CDATA[A paper* recently published in the peer-reviewed journal Vaccine** reports that Ceva’s new generation vaccine, Vectormune® AI, offers significant advantages over previously available vaccines against highly pathogenic avian influenza (HPAI).]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:21 +0200</pubDate>
        </item>
        <item>
            <title>Ceva posts strong double-digit growth again in 2014</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-posts-strong-double-digit-growth-again-in-2014</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-posts-strong-double-digit-growth-again-in-2014</guid>
            <description><![CDATA[Consolidated sales of the Ceva Group reached €766m at the end of 2014, representing growth of 23% and +14.1% at a constant perimeter and exchange rates.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:20 +0200</pubDate>
        </item>
        <item>
            <title>Troublesome cats get first online resource</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Troublesome-cats-get-first-online-resource</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Troublesome-cats-get-first-online-resource</guid>
            <description><![CDATA[A new online resource to help veterinary students, practitioners and pet owners better understand the undesirable behaviour of cats]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:20 +0200</pubDate>
        </item>
        <item>
            <title>Ceva “State of the Art” Summit at VIV Asia 2015</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-State-of-the-Art-Summit-at-VIV-Asia-2015</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-State-of-the-Art-Summit-at-VIV-Asia-2015</guid>
            <description><![CDATA[Ceva’s poultry, swine, services &amp; equipment teams will focus on what is “State of the Art” in animal production during the VIV Asia international trade show to be held in Bangkok from March 11th - 13th 2015.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:19 +0200</pubDate>
        </item>
        <item>
            <title>Ceva becomes official partner of Vet2011</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-becomes-official-partner-of-Vet2011</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-becomes-official-partner-of-Vet2011</guid>
            <description><![CDATA[2011 is World Veterinary year, let’s show pride in our profession “Vet for health, Vet for food, Vet for the planet!”.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:18 +0200</pubDate>
        </item>
        <item>
            <title>Happy new year 2015 !</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Happy-new-year-2015</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Happy-new-year-2015</guid>
            <description><![CDATA[Ceva Santé Animale wishes you all the best for 2015 !]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:17 +0200</pubDate>
        </item>
        <item>
            <title>Discover our newly redesigned website ceva.com !</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Discover-our-newly-redesigned-website-ceva.com</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Discover-our-newly-redesigned-website-ceva.com</guid>
            <description><![CDATA[To better meet your expectations, and improve user experience, our website has been completely revamped !]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:17 +0200</pubDate>
        </item>
        <item>
            <title>Tildren® receives FDA approval to control clinical signs of Navicular Syndrome</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Tildren-R-receives-FDA-approval-to-control-clinical-signs-of-Navicular-Syndrome</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Tildren-R-receives-FDA-approval-to-control-clinical-signs-of-Navicular-Syndrome</guid>
            <description><![CDATA[Tildren® is now available in the US]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:16 +0200</pubDate>
        </item>
        <item>
            <title>Egypt study confirms that a single rHVT-H5 hatchery vaccination could be an effective tool to address A/H5N1 prevention</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Egypt-study-confirms-that-a-single-rHVT-H5-hatchery-vaccination-could-be-an-effective-tool-to-address-A-H5N1-prevention</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Egypt-study-confirms-that-a-single-rHVT-H5-hatchery-vaccination-could-be-an-effective-tool-to-address-A-H5N1-prevention</guid>
            <description><![CDATA[Research confirms that in endemic countries the classical inactivated vaccines are less effective and hard to administer, while application of a rHVT vector hatchery vaccine is labour saving, cost effective and provides clinical protection against various types of H5N1 Highly Pathogenic Avian Influenza Virus after a single dose.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:15 +0200</pubDate>
        </item>
        <item>
            <title>Ceva US Joins Fear Free™ Initiative As Inaugural Industry Sponsor</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-US-Joins-Fear-Free-Initiative-As-Inaugural-Industry-Sponsor</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-US-Joins-Fear-Free-Initiative-As-Inaugural-Industry-Sponsor</guid>
            <description><![CDATA[Ceva today announced its commitment to Fear Free,™ an innovative initiative developed by “America’s Veterinarian” Dr. Marty Becker to in his words, “take the pet out of petrified and get pets back into practices.” The multi-year agreement aligns with Ceva’s leadership role and expertise in the area of pet behavior.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:15 +0200</pubDate>
        </item>
        <item>
            <title>Ceva Santé Animale reinforces its pharmaceutical production capacity, opening a new plant at its headquarters in Libourne France</title>
            <link>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-Sante-Animale-reinforces-its-pharmaceutical-production-capacity-opening-a-new-plant-at-its-headquarters-in-Libourne-France</link>
            <guid>https://www.ceva-biovac-campus.com/en/News-Media/News-Media/Ceva-Sante-Animale-reinforces-its-pharmaceutical-production-capacity-opening-a-new-plant-at-its-headquarters-in-Libourne-France</guid>
            <description><![CDATA[Libourne, 3 October 2014 – Ceva Santé Animale, the global veterinary health group, has invested €18 million in renovating and extending its sterile products plant in Libourne. The new industrial facility was inaugurated on 3 October and will increase injectable drug production capacity.]]></description>
            <pubDate>Sat, 29 Jul 2017 15:44:14 +0200</pubDate>
        </item>
    </channel>
</rss>
